Butkus D E, Meydrech E F, Raju S S
Department of Medicine, University of Mississippi Medical Center, Jackson 39216.
N Engl J Med. 1992 Sep 17;327(12):840-5. doi: 10.1056/NEJM199209173271203.
The long-term survival of cadaveric renal allografts is lower in black recipients than in white recipients, although the one-year graft survival is similar in these racial groups. We sought to determine what factors account for this disparity.
We studied 100 consecutive recipients of primary cadaveric renal allografts (57 were black and 43 white) at least 1 year after transplantation (mean, 40 months); all had received identical immunosuppressive therapy. We evaluated differences in the cause and duration of end-stage renal disease, the number of pretransplantation transfusions, age, matching for HLA-A, B, and DR antigens, race of the donor, insurance coverage, and compliance to assess their effect on graft survival in both groups.
Allograft survival after one year was significantly lower in black than in white patients (P = 0.025). According to univariate analysis, only the recipient's age at transplantation, the number of mismatches for HLA antigens, the type of insurance coverage, the source of referral for transplantation, and the degree of compliance correlated significantly with the rate of graft survival. The frequency of all variables that reduced graft survival was higher among the blacks. According to proportional-hazards analysis, the only factors contributing to a lower rate of graft survival were age of less than 30 years at transplantation (relative risk, 2.3; 95 percent confidence interval, 1.3 to 4.6), mismatches for all six HLA antigens as compared with three or fewer mismatches (relative risk, 5.6; 95 percent confidence interval, 3.3 to 9.6), and coverage by Medicaid or Medicare (relative risk, 2.2; 95 percent confidence interval, 1.5 to 3.2). Race had no additional effect. Noncompliance was more frequent among blacks (16 percent vs. 2 percent) and could substitute for insurance status in the model.
When immunosuppression is equivalent in black and white transplant recipients, apparently race-related differences in the long-term survival of renal cadaveric allografts appear to be related to other factors that affect graft survival unfavorably, notably poor HLA matching and unfavorable socioeconomic factors.
尸体肾移植受者中,黑人的长期存活率低于白人,尽管这两个种族群体的一年移植肾存活率相似。我们试图确定造成这种差异的因素。
我们研究了100例接受初次尸体肾移植的连续受者(57例为黑人,43例为白人),均在移植后至少1年(平均40个月);所有患者均接受相同的免疫抑制治疗。我们评估了终末期肾病的病因和病程、移植前输血次数、年龄、HLA - A、B和DR抗原配型、供者种族、保险覆盖情况以及依从性的差异,以评估它们对两组移植肾存活的影响。
黑人患者移植肾1年后的存活率显著低于白人患者(P = 0.025)。单因素分析显示,仅移植时受者年龄、HLA抗原错配数、保险覆盖类型、移植转诊来源以及依从程度与移植肾存活率显著相关。所有降低移植肾存活率的变量在黑人中的出现频率更高。多因素分析显示,导致移植肾存活率较低的唯一因素是移植时年龄小于30岁(相对危险度,2.3;95%可信区间,1.3至4.6)、6个HLA抗原均错配与错配3个或更少相比(相对危险度,5.6;95%可信区间,3.3至9.6)以及医疗补助或医疗保险覆盖(相对危险度,2.2;95%可信区间,1.5至3.2)。种族没有额外影响。黑人的不依从情况更常见(16%对2%),并且在模型中可替代保险状况。
当黑人和白人移植受者的免疫抑制相当,尸体肾移植长期存活率中明显的种族差异似乎与其他对移植肾存活有不利影响的因素有关,尤其是HLA配型不佳和不利的社会经济因素。